US Stock MarketDetailed Quotes
KNSA Kiniksa Pharmaceuticals
Watchlist
16.470
+0.300+1.86% Trading 12/01 14:27 ET
16.680High16.040Low180.01KVolume
16.040Open16.170Pre Close2.93MTurnover0.60%Turnover RatioLossP/E (TTM)1.16BMarket Cap20.65052wk High6.33P/E (Static)70.34MShares10.29052wk Low2.86P/B495.42MFloat Cap32.880Historical High--Dividend TTM30.08MShs Float5.010Historical Low--Div YieldTTM3.96%Amplitude16.287Avg Price1Lot Size
Kiniksa Pharmaceuticals Key Stats
Quarterly+Annual
YOY

(Q3)2023/09/30 | (Q2)2023/06/30 | (Q1)2023/03/31 | (FY)2022/12/31 | (Q4)2022/12/31 | (Q3)2022/09/30 | (Q2)2022/06/30 | (Q1)2022/03/31 | (FY)2021/12/31 | (Q4)2021/12/31 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -32.37%67.05M | 164.99%71.47M | 50.19%48.35M | 471.24%220.18M | 230.14%61.88M | 719.64%99.14M | 250.10%26.97M | 32.19M | 38.54M | 18.75M |
Operating revenue | -32.37%67.05M | 164.99%71.47M | 50.19%48.35M | 471.24%220.18M | 230.14%61.88M | 719.64%99.14M | 250.10%26.97M | --32.19M | --38.54M | --18.75M |
Cost of revenue | 128.37%26.4M | 149.22%21.69M | 22.86%15.32M | 151.59%22.9M | -354.43%-9.84M | 317.78%11.56M | 252.84%8.7M | 12.47M | 9.1M | 3.87M |
Gross profit | -53.59%40.65M | 172.50%49.79M | 67.48%33.02M | 570.03%197.29M | 382.07%71.72M | 838.84%87.58M | 248.82%18.27M | 19.72M | 29.44M | 14.88M |
Operating expense | 25.30%51.57M | 40.66%52.94M | 2.75%44.22M | 0.77%187.51M | 28.75%65.68M | 2.92%41.16M | -17.81%37.64M | -12.68%43.04M | 18.25%186.08M | -3.57%51.01M |
Selling and administrative expenses | 39.68%34.47M | 22.37%29.18M | 30.73%29.05M | 13.97%97.95M | 19.67%27.22M | 18.87%24.68M | 9.12%23.84M | 7.85%22.22M | 89.64%85.95M | 46.72%22.74M |
Research and development costs | 3.77%17.11M | 72.25%23.77M | -27.12%15.17M | -34.05%65.49M | -47.54%14.39M | -14.30%16.49M | -42.38%13.8M | -27.42%20.82M | -11.38%99.3M | -26.65%27.43M |
Other operating expenses | ---- | ---- | ---- | 2,782.75%24.07M | ---- | ---- | ---- | ---- | --835K | ---- |
Operating profit | -123.54%-10.93M | 83.72%-3.15M | 51.99%-11.2M | 106.24%9.77M | 116.74%6.05M | 251.35%46.41M | 52.24%-19.37M | 52.68%-23.32M | 0.46%-156.64M | 31.70%-36.13M |
Net non-operating interest income expense | 1,191.75%1.25M | -91.45%97K | 156.67%77K | |||||||
Non-operating interest income | ---- | ---- | ---- | 1,191.75%1.25M | ---- | ---- | ---- | ---- | -91.45%97K | 156.67%77K |
Other net income (expense) | 654.04%2.43M | 1,759.22%1.92M | 5,288.24%1.83M | 322K | 103K | 34K | ||||
Other non- operating income (expenses) | 654.04%2.43M | 1,759.22%1.92M | 5,288.24%1.83M | ---- | ---- | --322K | --103K | --34K | ---- | ---- |
Income before tax | -118.19%-8.5M | 93.57%-1.24M | 59.79%-9.36M | 107.04%11.03M | 118.97%6.84M | 252.42%46.74M | 52.49%-19.27M | 52.74%-23.29M | -0.20%-156.54M | 31.80%-36.05M |
Income tax | 103.02%5.36M | -2,364.11%-16.21M | 50.96%2.91M | -12,543.10%-172.34M | 753.05%2.38M | -150,203.39%-177.36M | -29.39%716K | 816.67%1.93M | -73.12%1.39M | -64.64%279K |
Net income | -106.18%-13.86M | 174.93%14.97M | 51.33%-12.27M | 216.11%183.36M | 112.28%4.46M | 833.67%224.09M | 51.93%-19.98M | 49.05%-25.21M | 2.14%-157.92M | 32.29%-36.33M |
Net income continuous Operations | -106.18%-13.86M | 174.93%14.97M | 51.33%-12.27M | 216.11%183.36M | 112.28%4.46M | 833.67%224.09M | 51.93%-19.98M | 49.05%-25.21M | 2.14%-157.92M | 32.29%-36.33M |
Minority interest income | ||||||||||
Net income attributable to the parent company | -106.18%-13.86M | 174.93%14.97M | 51.33%-12.27M | 216.11%183.36M | 112.28%4.46M | 833.67%224.09M | 51.93%-19.98M | 49.05%-25.21M | 2.14%-157.92M | 32.29%-36.33M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | -106.18%-13.86M | 174.93%14.97M | 51.33%-12.27M | 216.11%183.36M | 112.28%4.46M | 833.67%224.09M | 51.93%-19.98M | 49.05%-25.21M | 2.14%-157.92M | 32.29%-36.33M |
Basic earnings per share | -106.19%-0.2 | 172.41%0.21 | 50.00%-0.18 | 214.78%2.64 | 111.32%0.06 | 834.09%3.23 | 52.46%-0.29 | 50.00%-0.36 | 11.88%-2.3 | 32.91%-0.53 |
Diluted earnings per share | -106.29%-0.2 | 172.41%0.21 | 50.00%-0.18 | 213.04%2.6 | 111.32%0.06 | 822.73%3.18 | 52.46%-0.29 | 50.00%-0.36 | 11.88%-2.3 | 32.91%-0.53 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Paper Trade
Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--